Less than an hour after Kacsmaryk’s ruling on April 7, a federal judge in Washington state ordered the FDA to maintain the status-quo availability of mifepristone in 17 states and Washington, D.C., while a different lawsuit over abortion pills plays out. In that case, a group of attorneys general alleged that the FDA’s current restrictions on distributing mifepristone unnecessarily hinder access. เว็บคาสิโนออนไลน์